Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-8-25
|
pubmed:abstractText |
This randomized double-blind parallel group study characterized the pharmacokinetics of the calcium channel antagonist, nisoldipine (core-coat tablets), administered once daily for 7 days in doses of 5 mg (n = 12), 10 mg (n = 13), 20 mg (n = 12), and 30 mg (n = 11) to patients with mild to moderate hypertension. Serial blood samples were obtained from 0 to 24 hours and from 0 to 48 hours after nisoldipine administration on days 1 and 7, respectively. Nisoldipine plasma concentrations were determined by gas chromatography with electron capture detection. No statistically significant difference was found in dose-normalized area under the curve between the four groups. Area under the curve (standardized to body weight) correlated to dose (r = .74, P less than .05). No significant difference existed in oral clearance (L/h/kg) when analyzed for equivalence across the four doses: 8.21 +/- 3.47 (5 mg), 11.84 +/- 13.85 (10 mg), 11.48 +/- 7.49 (20 mg), and 10.36 +/- 5.49 (30 mg). The present investigation characterizes the pharmacokinetics of nisoldipine core-coat tablets in hypertensive patients and demonstrates the dose proportionality or linearity of nisoldipine plasma concentrations and area under the curve, measured over a dose range of 5 to 30 mg.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0091-2700
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
571-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1634646-Adult,
pubmed-meshheading:1634646-Aged,
pubmed-meshheading:1634646-Chemistry, Pharmaceutical,
pubmed-meshheading:1634646-Delayed-Action Preparations,
pubmed-meshheading:1634646-Double-Blind Method,
pubmed-meshheading:1634646-Drug Administration Schedule,
pubmed-meshheading:1634646-Female,
pubmed-meshheading:1634646-Humans,
pubmed-meshheading:1634646-Hypertension,
pubmed-meshheading:1634646-Male,
pubmed-meshheading:1634646-Middle Aged,
pubmed-meshheading:1634646-Nisoldipine,
pubmed-meshheading:1634646-Tablets
|
pubmed:year |
1992
|
pubmed:articleTitle |
Multiple dose pharmacokinetics of four different doses of nisoldipine in hypertensive patients.
|
pubmed:affiliation |
Drug Product Evaluation Unit, University of Kentucky Medical Center, Lexington.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|